Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
A focus on the latest non-invasive cardiac multi-modality imaging applications, and in particular onechocardiography in heart diseases.
I SESSION Role of imaging in patients with stroke15.00 - 15.15 Cardiac source of embolism15.15 - 15.30 How to understand patent foramen ovale clinical significance15.30 - 15.45 Patients with atrial fibrillation: does imaging add to CHADVASC?15.45 - 16.00 The role of multimodality imaging16.00 - 16.15 Discussion16.15 - 16.45 Hypertrophic Cardiomyopathy: A decade of progressII SESSION Asymptomatic valvular disease: which imaging arguments to operate……or not ?17.00 - 17.15 Severe mitral regurgitation17.15 - 17.30 Severe aortic stenosis17.30 - 17.45 Severe aortic insufficiency17.45 - 18.00 Severe tricuspid regurgitation18.00 - 18.15 DiscussionIII SESSION Interactive clinical cases. Part 118.15 - 19.00IV SESSION19.00 - 19.30 Practical sessionV SESSION Incremental role of imaging in patients with arterial hypertension09.00 - 09.15 Cardiac remodeling and LV function in patients with hypertension: which news?09.15 - 09.30 Is there a place for imaging in primary and secondary prevention?09.30 - 09.50 Treatment of arterial hyper tension: state of the art09.50 - 10.10 Discussion10.10 - 10.30 Lecture: hypertension and obesity “a common but bad marriage”VI SESSION Imaging patient with dyspnoea10.30 - 10.45 Pericardial disease10.45 - 11.00 Pulmonary embolism11.00 - 11.15 Acute valvular disease11.15 - 11.30 Prosthetic valve dysfunction11.30 - 11.45 DiscussionVII SESSION11.45 - 12.30 Clinical cases. Part 2VIII SESSION12.30 - 13.00 Practical session
15.00 - 15.30 Lecture: “Heart Failure” from imaging to treatment efficacy.I SESSION Heart failure with preserved ejection fraction: state of the art15.30 - 15.45 Which news from the ESC guidelines 2016?15.45 - 16.00 Is systolic left ventricular function really normal?16.00 - 16.15 Role of exercise stress-echo16.15 - 16.30 Focal or interstitial CMR fibrosis: does it matter?16.30 - 16.45 Discussion16.45 - 17.15 BreakII SESSION Management of endocarditis in the era of multimodality imaging17.15 - 17.30 Role of echocardiography17.30 - 17.45 Role of CT and CMR17.45 - 18.00 Role of nuclear medicine18.00 - 18.20 Complications of Endocarditis: what the mind does not know, eyes do not see18.20 - 18.40 Discussion18.40 -19.10 Lecture: Bicuspid Valve state of the art.
III SESSION State of the art in “Imaging in ischemic heart disease”09.00 - 09.15 Echocardiography: is it required in all patients?... Which stress for which patients?...Echocontrastography?09.15 - 09.30 Computed tomography(CT): from anatomical to functional imaging09.30 - 09.45 Cardiovascular Magnetic Resonance (CMR): ventricular function, myocardialfibrosis, perfusion and more...09.45 - 10.00 Nuclear medicine: role of fusion imaging10.00 - 10.20 Which news in the treatment of ischemic heart disease10.20 - 10.45 DiscussionIV SESSION Myocardial strain and vortex imaging10.45 - 11.00 Use of deformation in clinical practice: tips and tricks11.00 - 11.15 Use of deformation in cardiac resynchronization therapy11.15 - 11.30 Use of deformation for inducible ischemia assessment11.30 - 11.45 Use of vortex imaging in clinical practise: tips and tricks11.45 - 12.15 Discussion12.15 - 13.15 BRUNCHV SESSION Role of imaging in oncology13.15 - 13.30 Cardiac dysfunction in patients after cancer treatment: cardiac and oncologicalimplications13.30 - 13.45 Role of imaging for the detection of subclinical dysfunction13.45 - 14.00 Vascular disease as a consequence of cancer therapy: state of the heart14.00 - 14.15 Discussion14.15 - 14.45 Prevention of embolic stroke in atrial fibrillation. Which says the lastESC guidelines?VI SESSION Imaging in rare cardiomyopathies.14.45 - 15.00 Hypereosinophilia15.00 - 15.15 Amyloidosis15.15 - 15.30 Left ventricular non compaction15.30 - 15.45 Discussion15.45 - 16.00 Closure and CME evaluation
Hilton Giardini NaxosVia Jannuzzo, 47 - 98035 Giardini Naxos (ME), Italytel. +39 0942 51931 fax +39 0942 56128
European Society of Cardiology
European Heart HouseLes Templiers2035 Route des CollesCS 80179 BIOT
06903 Sophia Antipolis, FR
© 2017 European Society of Cardiology. All rights reserved